About
Silvec develops proprietary RNA-based therapies that provide long-lasting protection for trees, vines, and bushes against viral, bacterial, and fungal diseases without altering the host genome.
Explore Silvec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.